Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-21-008810
Filing Date
2021-02-12
Accepted
2021-02-12 13:02:27
Documents
3
Group Members
DANIEL HOPPDH-CAPITAL GMBH & CO. KGDIETMAR HOPPDR. MATHIAS HOTHUMOH BETEILIGUNGEN GMBH & CO. KGOLIVER HOPPPROF. DR. CHRISTOF HETTICHPROF. DR. FRIEDRICH VON BOHLEN UND HALBACH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea135278-13gdievini_immatics.htm SC 13G 309236
2 POWER OF ATTORNEY ea135278ex99-1_immatics.htm EX-99.1 25701
3 JOINT FILING STATEMENT ea135278ex99-2_immatics.htm EX-99.2 10339
  Complete submission text file 0001213900-21-008810.txt   347148
Mailing Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190
Business Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190 62278608462
dievini Hopp BioTech holding GmbH & Co KG (Filed by) CIK: 0001696029 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G

Mailing Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076
Business Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076 49 7071 5397 700
Immatics N.V. (Subject) CIK: 0001809196 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91607 | Film No.: 21625043
SIC: 2836 Biological Products, (No Diagnostic Substances)